Bluejay Diagnostics BJDX
NASDAQ BJDX
$0.91 -0.03 (-3.02%)
At close: Aug 21, 2026 · 4:00 PM EDT

Bluejay Diagnostics (BJDX) Long-Term Debt Issuances (2021)

Bluejay Diagnostics (BJDX) posted Long-Term Debt Issuances of -$4.2 million for Q4 2021, down 380.69% sequentially from $1.5 million in Q3 2021.

Bluejay Diagnostics (BJDX) Long-Term Debt Issuances (2021) Analysis & Trends

Bluejay Diagnostics has reported Long-Term Debt Issuances for 1 years, with the latest figure at -$4.2 million in Q4 2021.

  • Quarterly Long-Term Debt Issuances changed N/A year-over-year to -$4.2 million in Q4 2021, while the trailing twelve-month figure through Dec 2024 was -$2.7 million (changed N/A YoY) and the FY2024 annual result came in at $2.0 million, changed N/A from the prior year.
  • Long-Term Debt Issuances fell to -$4.2 million in Q4 2021 per BJDX's latest filing, from $1.5 million in the prior quarter.
  • Over five years, Long-Term Debt Issuances peaked at $2.7 million in Q2 2021 and troughed at -$4.2 million in Q4 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn -33.00 Mn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn -
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn -
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn -
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn -
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn -
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn 109.26 Mn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn -
10 Bluejay Diagnostics 1.89 Mn 1.89 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2021 -4.21 Mn
Dec 31, 2021 -4.21 Mn
Sep 30, 2021 1.50 Mn
Sep 30, 2021 1.50 Mn
Jun 30, 2021 2.73 Mn
Jun 30, 2021 2.73 Mn
Mar 31, 2021 268,000.00
Mar 31, 2021 268,000.00